EP2485740A4 - Methods for preventing or treating sarcopenia and muscle atrophy in animals - Google Patents

Methods for preventing or treating sarcopenia and muscle atrophy in animals

Info

Publication number
EP2485740A4
EP2485740A4 EP10822363A EP10822363A EP2485740A4 EP 2485740 A4 EP2485740 A4 EP 2485740A4 EP 10822363 A EP10822363 A EP 10822363A EP 10822363 A EP10822363 A EP 10822363A EP 2485740 A4 EP2485740 A4 EP 2485740A4
Authority
EP
European Patent Office
Prior art keywords
animals
preventing
methods
muscle atrophy
treating sarcopenia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP10822363A
Other languages
German (de)
French (fr)
Other versions
EP2485740A1 (en
EP2485740B1 (en
Inventor
Yuanlong Pan
Sunil Kochhar
Serge Andre Dominique Rezzi
Francoise-Pierre Martin
Emma Pere-Trepat
Sebastiano Collino
Vera Francia Arce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA filed Critical Nestec SA
Publication of EP2485740A1 publication Critical patent/EP2485740A1/en
Publication of EP2485740A4 publication Critical patent/EP2485740A4/en
Application granted granted Critical
Publication of EP2485740B1 publication Critical patent/EP2485740B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
EP10822363.7A 2009-10-09 2010-10-08 Methods for preventing or treating sarcopenia and muscle atrophy in animals Active EP2485740B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27863309P 2009-10-09 2009-10-09
PCT/US2010/002722 WO2011043827A1 (en) 2009-10-09 2010-10-08 Methods for preventing or treating sarcopenia and muscle atrophy in animals

Publications (3)

Publication Number Publication Date
EP2485740A1 EP2485740A1 (en) 2012-08-15
EP2485740A4 true EP2485740A4 (en) 2013-04-03
EP2485740B1 EP2485740B1 (en) 2018-08-29

Family

ID=43857050

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10822363.7A Active EP2485740B1 (en) 2009-10-09 2010-10-08 Methods for preventing or treating sarcopenia and muscle atrophy in animals

Country Status (12)

Country Link
US (1) US9301941B2 (en)
EP (1) EP2485740B1 (en)
JP (1) JP6122638B2 (en)
CN (1) CN102573857A (en)
AU (1) AU2010303872B2 (en)
BR (1) BR112012008238A2 (en)
CA (1) CA2776950C (en)
ES (1) ES2688447T3 (en)
IN (1) IN2012DN02624A (en)
MX (1) MX2012004118A (en)
RU (1) RU2558534C2 (en)
WO (1) WO2011043827A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11090313B2 (en) 2010-05-20 2021-08-17 University Of Iowa Research Foundation Methods for inhibiting muscle atrophy
CN104080454B (en) * 2011-06-06 2017-02-15 爱荷华大学研究基金会 Methods of inhibiting muscle atrophy
US9913823B2 (en) * 2011-10-18 2018-03-13 Amorepacific Corporation SIRT 1 activator including syringaresinol
AU2015254309B2 (en) * 2014-04-28 2020-02-27 Suntory Holdings Limited Muscle atrophy inhibitor containing quercetin glycoside
EP3256004A1 (en) 2015-02-13 2017-12-20 Mars, Incorporated Pet food feeding system
KR20170002846A (en) 2015-06-30 2017-01-09 (주)아모레퍼시픽 Composition containing extract of soybean leaves for suppressing and preventing myopathy
GB201522304D0 (en) * 2015-12-17 2016-02-03 Mars Inc Food product for reducing muscle breakdown
CN108635571B (en) * 2018-07-19 2021-10-22 西安交通大学医学院第一附属医院 Application of irisin in preparation of medicine for preventing and treating severe acute pancreatitis
AU2020356989A1 (en) * 2019-10-04 2022-05-26 Suntory Holdings Limited Composition for suppression of decrease in muscle mass, prevention of decrease therein, maintenance thereof, recovery thereof or increase therein
KR102623198B1 (en) * 2020-02-26 2024-01-10 한국 한의학 연구원 Compositions for preventing, ameliorating or treating for muscle strengthening, muscle development, muscle differentiation, muscle regeneration or sarcopenia comprising Glycine soja extract as effective component
RU2756154C1 (en) * 2020-11-13 2021-09-28 Митхат Зульфугар-Оглы Гасанов Method for diagnosing sarcopenia in patients with stage 5 chronic kidney disease receiving treatment with long-term hemodialysis
WO2023140407A1 (en) * 2022-01-21 2023-07-27 경상국립대학교병원 Pharmaceutical composition comprising coumestrol for preventing or treating sarcopenia

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163746A (en) * 1973-07-09 1979-08-07 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Metabolic 5-methyl-isoflavone-derivatives, process for the preparation thereof and compositions containing the same
US20030021858A1 (en) * 2000-05-22 2003-01-30 Bababunmi Enitan A. Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease
EP1329222A1 (en) * 2001-12-18 2003-07-23 Daicho Kikaku Incorporated Company Isoflavone compositions for use in medicine
WO2005089567A1 (en) * 2004-03-17 2005-09-29 Nestec S.A. Compositions and methods for reducing or preventing obesity
WO2007134867A2 (en) * 2006-05-24 2007-11-29 Dsm Ip Assets B.V. Treating muscular disorders and improving muscular function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1192943A3 (en) * 2000-09-28 2002-11-27 Pfizer Products Inc. Use of growth hormone secretagogues in conjunction with physical exercise
AUPR846401A0 (en) * 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same
US20070185012A1 (en) * 2003-07-10 2007-08-09 Rajadhyaksha V J Glycopeptides for the treatment of als and other metabolic and autoimmune disorders
JP2007519743A (en) * 2004-01-29 2007-07-19 エリクシアー ファーマシューティカルズ， インコーポレイテッド Treatment of virus failure
EP2054049B1 (en) * 2006-08-24 2016-04-13 University of Tennessee Research Foundation Substituted acylanilides and methods of use thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163746A (en) * 1973-07-09 1979-08-07 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Metabolic 5-methyl-isoflavone-derivatives, process for the preparation thereof and compositions containing the same
US20030021858A1 (en) * 2000-05-22 2003-01-30 Bababunmi Enitan A. Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease
EP1329222A1 (en) * 2001-12-18 2003-07-23 Daicho Kikaku Incorporated Company Isoflavone compositions for use in medicine
WO2005089567A1 (en) * 2004-03-17 2005-09-29 Nestec S.A. Compositions and methods for reducing or preventing obesity
WO2007134867A2 (en) * 2006-05-24 2007-11-29 Dsm Ip Assets B.V. Treating muscular disorders and improving muscular function

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AUBERTIN-LEHEUDRE M ET AL: "Six months of isoflavone supplement increases fat-free mass in obese-sarcopenic postmenopausal women: a randomized double-blind controlled trial", EUROPEAN JOURNAL OF CLINICAL NUTRITION, NATURE PUBLISHING GROUP, GB, vol. 61, no. 12, 1 December 2007 (2007-12-01), pages 1442 - 1444, XP009100571, ISSN: 0954-3007, DOI: 10.1038/SJ.EJCN.1602695 *
See also references of WO2011043827A1 *

Also Published As

Publication number Publication date
MX2012004118A (en) 2012-05-08
CN102573857A (en) 2012-07-11
AU2010303872A1 (en) 2012-04-19
CA2776950C (en) 2023-11-21
EP2485740A1 (en) 2012-08-15
AU2010303872B2 (en) 2016-06-23
JP2013507361A (en) 2013-03-04
JP6122638B2 (en) 2017-04-26
RU2558534C2 (en) 2015-08-10
RU2012118686A (en) 2013-11-20
ES2688447T3 (en) 2018-11-02
CA2776950A1 (en) 2011-04-14
WO2011043827A1 (en) 2011-04-14
US9301941B2 (en) 2016-04-05
EP2485740B1 (en) 2018-08-29
IN2012DN02624A (en) 2015-05-22
US20120238515A1 (en) 2012-09-20
BR112012008238A2 (en) 2017-06-06

Similar Documents

Publication Publication Date Title
EP2485740A4 (en) Methods for preventing or treating sarcopenia and muscle atrophy in animals
EP2396019A4 (en) Method and compositions for treating skin
IL202015A0 (en) Methods and compositions for treating skin conditions
HK1162451A1 (en) Wastewater treatment apparatus and method
EP2428191A4 (en) Apparatus and method for treating excreta
HK1162366A1 (en) Devices and methods for treating and or preventing diseases
EP2463241A4 (en) Water treatment device and water treatment method
IL210097A0 (en) Compositions and methods for treating unfluenza
EP2362770A4 (en) Compositions and methods for treating or preventing radiation injury
EP2497482A4 (en) Composition for preventing and treating influenza-virus-induced diseases
ZA201101213B (en) Compositions and methods for treating disorders associated with overweight animals
GB201212490D0 (en) System and method for treating fish
ZA200906541B (en) Compositions and methods for preventing or treating obesity in animals
EP2504428A4 (en) Methods and compositions for treating oxalate-related conditions
EP2429584A4 (en) Methods and compositions for treatment
IL216146A0 (en) Methods and compositions for treating lupus
GB2473749B (en) Waste treatment apparatus and method
IL184441A0 (en) Method and device for water treatment
EP2416107A4 (en) Blast treatment method and blast treatment device
EP2485738A4 (en) Compositions and methods for treating obesity
HK1183766A1 (en) Compositions and methods for treating bruises
EP2343402A4 (en) Electrolytic treatment method and electrolytic treatment device
EP2155239A4 (en) Methods for decreasing immune response and treating immune conditions
EP2608794A4 (en) Methods and compositions for preventing or treating obesity
GB2466563B (en) Treatment apparatus and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120330

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20130306

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/343 20060101ALI20130228BHEP

Ipc: A23L 1/30 20060101ALI20130228BHEP

Ipc: A61P 21/00 20060101ALI20130228BHEP

Ipc: A23K 1/18 20060101ALI20130228BHEP

Ipc: A23L 1/29 20060101ALI20130228BHEP

Ipc: A61K 31/352 20060101ALI20130228BHEP

Ipc: A61K 31/35 20060101ALI20130228BHEP

Ipc: A23K 1/16 20060101AFI20130228BHEP

Ipc: A61K 31/353 20060101ALI20130228BHEP

Ipc: A61K 31/366 20060101ALI20130228BHEP

17Q First examination report despatched

Effective date: 20140923

17Q First examination report despatched

Effective date: 20140924

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602010053188

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61K0031785000

Ipc: A61K0031343000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/343 20060101AFI20180419BHEP

Ipc: A61K 31/366 20060101ALI20180419BHEP

Ipc: A23K 20/10 20160101ALI20180419BHEP

Ipc: A61K 31/35 20060101ALI20180419BHEP

Ipc: A61K 31/352 20060101ALI20180419BHEP

Ipc: A61P 21/00 20060101ALI20180419BHEP

Ipc: A61K 31/353 20060101ALI20180419BHEP

INTG Intention to grant announced

Effective date: 20180522

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1034324

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180915

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602010053188

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2688447

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20181102

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181129

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181130

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181229

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181129

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1034324

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180829

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

Ref country code: DE

Ref legal event code: R097

Ref document number: 602010053188

Country of ref document: DE

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20181031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181008

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

REG Reference to a national code

Ref country code: NL

Ref legal event code: PD

Owner name: SOCIETE DES PRODUITS NESTLE S.A.; CH

Free format text: DETAILS ASSIGNMENT: CHANGE OF OWNER(S), MERGE; FORMER OWNER NAME: NESTEC S.A.

Effective date: 20190620

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: SOCIETE DES PRODUITS NESTLE S.A.

26N No opposition filed

Effective date: 20190531

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20190801 AND 20190807

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181031

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181031

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181031

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181008

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602010053188

Country of ref document: DE

Representative=s name: MITSCHERLICH, PATENT- UND RECHTSANWAELTE PARTM, DE

Ref country code: DE

Ref legal event code: R081

Ref document number: 602010053188

Country of ref document: DE

Owner name: SOCIETE DES PRODUITS NESTLE S.A., CH

Free format text: FORMER OWNER: NESTEC S.A., VEVEY, CH

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180829

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180829

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20101008

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230527

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20230915

Year of fee payment: 14

Ref country code: IT

Payment date: 20230913

Year of fee payment: 14

Ref country code: IE

Payment date: 20230912

Year of fee payment: 14

Ref country code: GB

Payment date: 20230831

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230911

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20231108

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20230830

Year of fee payment: 14